Cargando…

CCN2 Enhances Resistance to Cisplatin-Mediating Cell Apoptosis in Human Osteosarcoma

Osteosarcoma (OS) is the most common form of malignant bone tumor and is an aggressive malignant neoplasm exhibiting osteoblastic differentiation. Cisplatin is one of the most efficacious antitumor drugs for osteosarcoma patients. However, treatment failures are common due to the development of chem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsai, Hsiao-Chi, Huang, Chun-Yin, Su, Hong-Lin, Tang, Chih-Hsin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956456/ https://www.ncbi.nlm.nih.gov/pubmed/24637722 http://dx.doi.org/10.1371/journal.pone.0090159

Ejemplares similares

CCN6-mediated MMP-9 activation enhances metastatic potential of human chondrosarcoma
por: Tzeng, Huey-En, et al.
Publicado: (2018)

Interferon-α suppresses invasion and enhances cisplatin-mediated apoptosis and autophagy in human osteosarcoma cells
por: ZHAO, JUN, et al.
Publicado: (2014)

Targeting CCN Proteins in Rheumatoid Arthritis and Osteoarthritis
por: MacDonald, Iona J., et al.
Publicado: (2021)

CTGF increases matrix metalloproteinases expression and subsequently promotes tumor metastasis in human osteosarcoma through down-regulating miR-519d
por: Tsai, Hsiao-Chi, et al.
Publicado: (2014)

MicroRNA-584 Impairs Cellular Proliferation and Sensitizes Osteosarcoma Cells to Cisplatin and Taxanes by Targeting CCN2
por: Li, Li, et al.
Publicado: (2020)

Correction: CTGF increases matrix metalloproteinases expression and subsequently promotes tumor metastasis in human osteosarcoma through down-regulating miR-519d
por: Tsai, Hsiao-Chi, et al.
Publicado: (2020)

CCN1 Induces Oncostatin M Production in Osteoblasts via Integrin-Dependent Signal Pathways
por: Chen, Cheng-Yu, et al.
Publicado: (2014)

MicroRNA-22 regulates autophagy and apoptosis in cisplatin resistance of osteosarcoma
por: Meng, Chen-Yang, et al.
Publicado: (2020)

The CCN Family Proteins: Modulators of Bone Development and Novel Targets in Bone-Associated Tumors
por: Chen, Po-Chun, et al.
Publicado: (2014)

Resistin enhances angiogenesis in osteosarcoma via the MAPK signaling pathway
por: Tsai, Hsiao-Chi, et al.
Publicado: (2019)

The matrix protein CCN1 (CYR61) induces apoptosis in fibroblasts
por: Todorovicç, Viktor, et al.
Publicado: (2005)

Checkpoint kinase inhibitor AZD7762 enhance cisplatin-induced apoptosis in osteosarcoma cells
por: Zhu, Jian, et al.
Publicado: (2019)

WISP-1 positively regulates angiogenesis by controlling VEGF-A expression in human osteosarcoma
por: Tsai, Hsiao-Chi, et al.
Publicado: (2017)

Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin
por: Qu, Yang, et al.
Publicado: (2022)

PINK1 regulates apoptosis of osteosarcoma as the target gene of cisplatin
por: Si, Zhenxing, et al.
Publicado: (2023)

CCN3 promotes epithelial-mesenchymal transition in prostate cancer via FAK/Akt/HIF-1α-induced twist expression
por: Chen, Po-Chun, et al.
Publicado: (2017)

Identification of genes contributing to cisplatin resistance in osteosarcoma cells
por: Xie, Mingzhong, et al.
Publicado: (2022)

Enhancement of CCL2 expression and monocyte migration by CCN1 in osteoblasts through inhibiting miR-518a-5p: implication of rheumatoid arthritis therapy
por: Chen, Cheng-Yu, et al.
Publicado: (2017)

Single nucleotide mutation changes the capability of CCN3 in osteosarcoma cell invasion and differentiation
por: Yan, Xuejing, et al.
Publicado: (2022)

Proteasome Inhibitor MG132 Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells and Inhibits Tumor Growth
por: Sun, Farui, et al.
Publicado: (2018)

Knockdown of Akt Sensitizes Osteosarcoma Cells to Apoptosis Induced by Cisplatin Treatment
por: Zhang, Guoyou, et al.
Publicado: (2011)

Enhanced Stim1 expression is associated with acquired chemo-resistance of cisplatin in osteosarcoma cells
por: Sun, Xilong, et al.
Publicado: (2017)

ITGB3 promotes cisplatin resistance in osteosarcoma tumors
por: Li, Qian, et al.
Publicado: (2023)

MiR-138 Acts as a Tumor Suppressor by Targeting EZH2 and Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells
por: Zhu, Ziqiang, et al.
Publicado: (2016)

Chemokine Ligand 2 Promotes Migration in Osteosarcoma by Regulating the miR-3659/MMP-3 Axis
por: Chang, Yu-Hsiang, et al.
Publicado: (2023)

Prostate cancer-derived CCN3 induces M2 macrophage infiltration and contributes to angiogenesis in prostate cancer microenvironment
por: Chen, Po-Chun, et al.
Publicado: (2014)

Efficacy of celastrol combined with cisplatin in enhancing the apoptosis of U-2OS osteosarcoma cells via the mitochondrial and endoplasmic reticulum pathways of apoptosis
por: Wang, Qiang, et al.
Publicado: (2019)

Silencing of Barkor/ATG14 sensitizes osteosarcoma cells to cisplatin-induced apoptosis
por: ZHAO, ZHIFANG, et al.
Publicado: (2014)

PERK-mediated Autophagy in Osteosarcoma Cells Resists ER Stress-induced Cell Apoptosis
por: Ji, Guang-rong, et al.
Publicado: (2015)

CCL4 Stimulates Cell Migration in Human Osteosarcoma via the mir-3927-3p/Integrin αvβ3 Axis
por: Tsai, Hsiao-Chi, et al.
Publicado: (2021)

Combination therapy with cisplatin and nifedipine induces apoptosis in cisplatin-sensitive and cisplatin-resistant human glioblastoma cells.
por: Kondo, S., et al.
Publicado: (1995)

Circular RNA expression pattern in cisplatin-resistant osteosarcoma cells
por: Han, Jianhua, et al.
Publicado: (2020)

Metformin induces autophagy of cisplatin-resistant human gastric cancer cells in addition to apoptosis
por: Fang, Chih-Wun, et al.
Publicado: (2023)

CCN3 Facilitates Runx2 and Osterix Expression by Inhibiting miR-608 through PI3K/Akt Signaling in Osteoblasts
por: Chen, Po-Chun, et al.
Publicado: (2019)

Matricellular CCN proteins
por: Perbal, Bernard
Publicado: (2008)

The skinny on CCN2
por: Leask, Andrew
Publicado: (2008)

Manoalide Induces Intrinsic Apoptosis by Oxidative Stress and Mitochondrial Dysfunction in Human Osteosarcoma Cells
por: Yao, Zhi-Kang, et al.
Publicado: (2023)

New insight into CCN3 interactions - Nuclear CCN3 : fact or fantasy?
por: Perbal, Bernard
Publicado: (2006)

Yin and Yang: CCN3 inhibits the pro-fibrotic effects of CCN2
por: Leask, Andrew
Publicado: (2009)

Telomerase reverse transcriptase promotes chemoresistance by suppressing cisplatin-dependent apoptosis in osteosarcoma cells
por: Zhang, Zhengpei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_s7f621ngqukdu9gbn5j7pkj0g6